SCHEMBL8848920

SCHEMBL8848920

CC1(n2c(N)nc3nc(O)n(O)c3c2=O)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23263140 0.54 POLB (0.34) —
SCHEMBL24974761 0.51 KDM4E (0.32) —
SCHEMBL6048225 0.48 KDM4E (0.40) —
SCHEMBL29115820 0.47 HCAR1 (0.43) —
SCHEMBL29010976 0.47 MGLL (0.36) —
SCHEMBL17265901 0.47 — —
SCHEMBL23261982 0.45 POLB (0.32) —
SCHEMBL25157210 0.45 BRD4 (0.43) —
SCHEMBL24805060 0.44 NOTUM (0.39) —
SCHEMBL30145016 0.44 TSHR (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0809498-A1 NOVEL PHARMACEUTICAL COMBINATION Astra Aktiebolag (SE) 1997-12-03 — — EP disclosed
WO-1996024355-A1 NOVEL PHARMACEUTICAL COMBINATION ASTRA AKTIEBOLAG (SE) 1996-08-15 — — WO disclosed
Send feedback